Delivery Order SPE2DB20D3103-SPE2DB25FQ1D7
- Not listed
- The Defense Logistics Agency awarded a $30,970.59 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Kineret 100 mg/0.67 ml syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used primarily for treating rheumatoid arthritis and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. The contract is valued at $3,580.88 with a firm fixed price structure and an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Kineret (anakinra) 100 mg/0.67 mL syringes totaling $3,580.88 on July 31, 2025, with an ultimate completion date of August 21, 2025. This non-set-aside, firm fixed-price delivery order represents a pediatric or adult rheumatoid arthritis therapeutic supply under a competitive procurement process. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a contract ceiling value of $7,161.76 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $4,476.10 under a firm fixed-price contract. The order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that reflects the standard procurement approach used...
- This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the delivery of 4,564,159,150 units of the specialty pharmaceutical drug Kineret 100 mg/0.67 ml syringe. The contract has a firm fixed price and is a delivery order with an ultimate completion date of April 24, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Kineret 100 mg/0.67 mL syringes, a medication used to treat certain autoimmune disorders. The contract has a ceiling value of $7,161.76 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1D7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,161.76 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on September 2, 2025, with completion scheduled for September 23, 2025. This competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant human interleukin-1 receptor antagonist used to treat inflammatory conditions, representing the type of specialty pharmaceutical products that AmerisourceBergen supplies through its federal contracts. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor contract running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems and other federal agencies. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves critical federal medical procurement needs through a diverse portfolio spanning brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The contract structure enables flexible fulfillment of requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/2/25 |